The 2026 Health System Technology Agenda
The 2026 Health System Technology Agenda: 5 Key Takeaways Pharma Brand and Market Access Leaders Need to Know
The Health Management Academy's 2026 Technology Investment Survey gives Pharma Brand Leaders and Market Access Leaders an inside view into how 31 leading U.S. health systems are making technology decisions, where budgets are growing, and what it takes to be a partner worth keeping.
For Pharma Brand Leaders, this means the infrastructure through which patients access and stay on therapy is shifting in ways that create real openings — particularly for brands that bring more than a product to the table. For Market Access Leaders, it means the partnerships and data-sharing arrangements that underpin access programs are landing in front of decision-makers with higher expectations and less tolerance for complexity.
The Health Management Academy's 2026 Technology Investment Survey captures the perspective of senior technology executives — CIOs, CTOs, CDOs, CMIOs, and CNIOs — at health systems ranging from $500 million to more than $10 billion in annual operating revenue. The five findings summarized here are directly relevant to how pharma companies engage health systems today and position themselves for the partnerships that will define access tomorrow.
Understanding these technology priorities is one of the most important and underutilized advantages available to pharma commercial teams today, and this analysis was written to make that advantage accessible.
DownloadWe will contact you with more information.
What This Briefing Gives You
After reading this briefing, Pharma Brand Leaders and Market Access Leaders will have a clearer picture of the health system technology landscape and a sharper set of tools for engaging health system decision-makers at the level of partnership they expect.
If you are a Pharma Brand Leader or Market Access Leader seeking to deepen your engagement with health systems, the 2026 Technology Investment Survey from The Health Management Academy offers a critical lens into how health system technology executives are making investment decisions, who holds purchasing authority, and what they genuinely want from industry partners.
The findings reveal that the rules of engagement with health systems are shifting in ways that will directly affect how Brand Leaders position their therapies and support programs, and how Market Access Leaders navigate the access landscape, build system-level partnerships, and demonstrate value.
Understanding these shifts is no longer optional background knowledge...it is the foundation for earning a seat at the table with the executives who control the budgets, the workflows, and ultimately the infrastructure through which patients access care and therapies reach those who need them.
Download
About The Health Management Academy
Since 1998, The Health Management Academy has cultivated the premier membership-based community of healthcare’s most influential CXOs from top U.S. health systems, as well as decision makers from innovative industry companies.
We cultivate exceptional peer groups, providing original market insights, world-class leadership development programs, and novel member alliances to more than 2,000 health system senior executives and 200 industry organizations.
2,500+
Health System Executives
600+
Health System C-Suite Members
300+
Industry Members
28+
Years of Convening
